Keep Life
Moving

Regular Antigen Testing Can Identify
Active Infection of SARS-CoV-2.

Complement your
COVID-19 Testing Programs

Talis One™ delivers rapid, accurate point-of-care
molecular diagnostic testing into a variety of healthcare settings.

CLINICAL VALUE
OPERATIONAL EXCELLENCE

Fast, accurate, lab-quality molecular diagnostic testing for a variety of healthcare settings

Learn More

TEST TO STAY

Minimize Disruptions with Rapid COVID-19 Testing when and where it is needed

Learn More

EXCELLENCE
AT THE POINT OF CARE

With access to lab-quality molecular diagnostics at the point of need, clinicians get timely results for actionable decision making. In the future, our portfolio of point-of-care diagnostic tests will include:

Respiratory Health
  • COVID-19
  • COVID-19/ Influenza A/B
Sexual Health
  • CT/NG
  • CT/NG/Mgen/Trich
  • HSV
Women’s Health
  • UTI
  • Vaginitis
  • GBS

In development and not available for sale.

MEET THE
LOCALIZED SOLUTION

Talis strives to deliver excellence in diagnostics to help combat the spread of infectious disease. We deploy to various healthcare settings and offer lab-quality testing which is:

Accurate
Rapid
Easy-to-Use

See how you can drive better patient care with the Talis One™ test system.

Built Compact
For More Impact

The Talis One COVID-19 Test System is built with compact performance in mind. It offers a sample-to-answer molecular workflow which integrates sample preparation, nucleic acid extraction, purification, amplification, and detection of the viral genomic target sequence. 

Each Talis One test (shown here) employs a single-use, self-contained, room temperature stable test cartridge that includes the necessary reagents to perform the NAAT (Nucleic Acid Amplification Test.) 

Latest News

What is the difference between NAAT and PCR?

| Article | No Comments
While the COVID-19 pandemic has brought phrases like “PCR test” and “antigen test” into wider use, one term that hasn’t been talked about as much is “NAAT,” which is short…

The Talis One™ COVID-19 Test System is expected to accurately detect the new coronavirus variant Omicron

| News | No Comments
Talis conducted a comprehensive in silico assessment comparing the Omicron (B1.1.529) variant published sequences from the GISAID database to its Talis One COVID-19 Test System. The bioinformatics analysis concluded that…

Get in touch

Put the Talis One solution to work for you. Connect with us for information about our products and company updates.

Contact us